90岁后药物使用与多重用药的变化:丹麦1905队列纵向研究
该研究追踪丹麦1905年出生人群从92岁至100岁的自我报告规律用药,发现个体层面女性每年增加0.19种药物(95%CI=0.15-0.24)、男性每年增加0.15种(95%CI=0.06-0.24),而人群平均药物数从基线3.6种升至首次随访4.1种后稳定在约4种。
要点
- 92至100岁个体规律用药数量随年龄持续增加,女性年均增0.19种、男性0.15种。
- 人群平均药物数从3.6种升至4.1种后稳定于约4种,横断面分析难以察觉个体增长。
- 提前退出研究者基线用药更多且年均增长更陡,提示该群体用药负担更重。
核心结论
- 高龄老人个体层面规律用药数量随年龄增长而增加,但人群平均水平在首次随访后趋于稳定。
- 女性在所有随访波次中用药数量均多于男性。
- 需要更多研究理解该年龄段合理处方的标准。
研究设计与样本
- 纵向队列研究,1998、2000、2002和2005年共四轮调查。
- 丹麦全国范围招募1905年出生且存活者,1998年基线应答2262人。
- 采用自我报告的规律用药,以均数、中位数和增长曲线模型分析92至100岁的药物数变化。
主要发现
- 个体内药物使用随年龄增加:女性每年0.19种(95%CI=0.15-0.24),男性每年0.15种(95%CI=0.06-0.24)。
- 提前退出研究者基线药物数更高且年增长更陡。
- 人群平均药物数从基线3.6种增至首次随访4.1种,此后稳定在约4种。
- 女性在所有波次用药数均多于男性。
临床怎么用
- 对90岁以上老人应关注个体层面用药数量的逐年累积,而非仅看人群平均处方数。
- 对基线用药多、退出随访风险高的老人应加强用药审查与随访。
- 女性高龄老人用药数量更多,处方管理时需特别关注。
局限性
- 药物使用为自我报告,未报告具体药物类别或适应证。
- 队列仅限1905年出生丹麦人群,外推需谨慎。
- 提前退出研究者用药增长更陡,可能影响纵向估计的完整性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the longitudinal development of drug use in very old adults. DESIGN: Longitudinal cohort study with waves in 1998, 2000, 2002, and 2005. SETTING: Nationwide study in Denmark. PARTICIPANTS: All living Danes born in 1905 were approached in 1998; 2,262 responded at baseline. MEASUREMENTS: Self-reported use of regularly taken drugs. Mean and median number of drugs and growth curve models were used to identify the change in number of drugs as the cohort aged from 92 to 100. RESULTS: The within-person use of drugs increased with age for women (0.19 per year; 95% confidence interval (CI) = 0.15-0.24) and men (0.15 per year; 95% CI = 0.06-0.24). Persons leaving the study prematurely had higher baseline values and a steeper increase in their annual use of drugs. The population-level mean number of drugs increased from baseline (3.6 drugs) to the first follow-up (4.1 drugs) but thereafter remained stable at approximately 4 drugs. Women used more drugs than men at all waves. CONCLUSION: In this first longitudinal study of drug use in nonagenarians, individuals used an increasing number of drugs as they aged. This increase is difficult to detect in cross-sectional analyses of the population-level mean. More efforts to understand what is reasonable prescribing at these older ages are needed.
引用
- Wastesson JW, Oksuzyan A, von Bornemann Hjelmborg J, et al. Changes in Drug Use and Polypharmacy After the Age of 90: A Longitudinal Study of the Danish 1905 Cohort. J Am Geriatr Soc. 2016. PMID: 27891576. doi:10.1111/jgs.14416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。